We report on a folate sensitive fragile site at Xq27-28 in a girl with a multiple congenital anomalies and mental retardation syndrome, who also carries a duplication of the long arm of chromosome 8. The fragile site was shown by FISH to be distal to both FRAXA and FRAXE. DNA hybridisation with probe OxF14 showed the amplification of the CGG repeats of locus FRAXF in the patient and in her clinically normal mother. (JMed Genet 1996;33:611-614) 
FRAXA, mapping at Xq27.3, is the most frequent fragile site known to have clinical manifestations, namely the fragile X syndrome. The associated mutation is the result of an amplification of CGG triplet repeats in the FMR1 gene. 1-3 Since the identification of this mutation, many families ascertained through mental retardation and presenting a fragile site at Xq27-Xq28 have been shown not to have the FMR1 expansion. '4 Other families have been found with high levels of fragile X expression in unaffected people of both sexes.6 A second folate sensitive rare fragile site, FRAXE, was identified in some of these families, lying distal to FRAXA and proximal to DXS296.75 It was cloned by Knight et al9 and was shown to be associated with the expansion of a GCC trinucleotide repeat. More recently, a third rare fragile site, FRAXF, was mapped distally to DXS296 and consequently is distal to both FRAXA and FRAXE.'0 In 1994, Ritchie et all' cloned DNA sequences that included this fragile site which involved the expansion of a (GCCGTC)n(GCC)n compound array. Folate sensitivity of this fragile site was not precisely defined.
Here we report on a patient with FRAXF who also had a partial duplication of the long arm of chromosome 8.
Patient and methods

CLINICAL DATA
The patient, a girl, is the third child born to healthy, non-consanguineous parents. Her two brothers are phenotypically normal. She was born at term after an uneventful pregnancy. Her neuropsychomotor development was delayed. She was examined at 8 years of age (fig 1) and had severe mental retardation. Her height (125 cm), weight (30 3 kg), and head circumference (49-5 cm) were on the 3rd centile. Her expressionless face was wide and slightly asymmetrical. The forehead was narrow and facial dysmorphism included slight microphthalmia, blepharophimosis, epicanthic folds, apparent telecanthus, a broad nasal root, and a long philtrum. The palate was high arched and the teeth were irregularly implanted. The gingivae were hyperplastic and the upper frenulum was thick. The ears were small, low set, and posteriorly angulated, with abnormal folding of the helices. The neck was short and broad and the posterior hairline was low. The nipples were hypoplastic and widely spaced. original family reported by Hirst et al,'0 no fragile site was observed without induction in all but one person who also had the highest expression (26%). It was then suggested that FRAXF could be folate insensitive at least in those people manifesting it at high frequencies. Contrary to this, the fragile site in the patient described here was expressed in a higher proportion of cells (40%) in two independent cultures and was clearly folate sensitive. However, the fragility observed in the family reported by girl of the same family. The expanded alleles in the normal mother (A -1200 bp) and her affected daughter (A = 1000 bp) were methylated." In the mentally retarded male described by Ritchie et al,11 an amplification of 2000 bp was associated with methylation.
These data indicate a lack of association of mental retardation with FRAXF expansion and methylation. A bias of ascertainment through cytogenetic analysis of mentally retarded subjects would explain the number of affected people in whom FRAXF has been described.
